Corvus Pharmaceuticals, Inc. Annual Return On Assets in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Corvus Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2023.
  • Corvus Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -109 %, a 113% decline year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Return On Assets for 2023 was -50.6 %, a 4.83% decline from 2022.
  • Corvus Pharmaceuticals, Inc. annual Return On Assets for 2022 was -48.3 %, a 24.8% decline from 2021.
  • Corvus Pharmaceuticals, Inc. annual Return On Assets for 2021 was -38.7 %, a 350% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -50.6 -2.33 -4.83% Jan 1, 2023 Dec 31, 2023
2022 -48.3 -9.59 -24.8% Jan 1, 2022 Dec 31, 2022
2021 -38.7 -30.1 -350% Jan 1, 2021 Dec 31, 2021
2020 -8.58 +39.1 +82% Jan 1, 2020 Dec 31, 2020
2019 -47.7 -12.4 -35.1% Jan 1, 2019 Dec 31, 2019
2018 -35.3 +15.1 +29.9% Jan 1, 2018 Dec 31, 2018
2017 -50.4 -26.3 -109% Jan 1, 2017 Dec 31, 2017
2016 -24.1 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.